QuidelOrtho Corporation QDEL
14.09 USD +0.06 (+0.43%)
At closeNov 3, 2026, 4:00 PM EST
12.90 -1.19 -8.45%
After hours · Nov 3, 4:00 PM ET
13.37 Day range 14.59
9.92 52-week range 35.58
- YTD
- -50.67%
- 1 year
- -49.15%
Analyst view
Consensus: hold
Hold
Price target (mean) 14.67 +4.1% upside
Now 14.09
- Target (low)
- 12.00
- Target (mean)
- 14.67
- Target (high)
- 20.00
Ratings (0m) 3 1 buy · 1 hold · 1 sell
- Strong buy0
- Buy1
- Hold1
- Sell0
- Strong sell1
Recommendation trend
- This month 3
- 1 month ago 3
- 2 months ago 5
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.17953 | 0.17953 – 0.17953 | 0.80 | -77.6% | 628.07M | -10.3% | 1 |
| Next quarter | 0.46984 | 0.46984 – 0.46984 | 0.46 | +2.1% | 665.60M | -8.0% | 1 |
| Current year | 0.77449 | 0.74898 – 0.80 | 2.12 | -63.5% | 2.54B | -6.8% | 2 |
| Next year | 1.44 | 1.41 – 1.47 | 0.77449 | +86.2% | 2.59B | +1.8% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 8, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jul 1, 2026 | JP Morgan | Maintained | Underweight | Underweight |
| May 7, 2026 | Jefferies | Downgrade | Buy | Hold |
| May 6, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 10, 2026 | UBS | Maintained | Neutral | Neutral |
| Feb 12, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Jan 21, 2026 | UBS | Maintained | Neutral | Neutral |
| Nov 7, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Nov 6, 2025 | UBS | Maintained | Neutral | Neutral |
| Oct 7, 2025 | Citigroup | Downgrade | Buy | Neutral |
| Aug 7, 2025 | UBS | Maintained | Neutral | Neutral |
| Aug 6, 2025 | Citigroup | Maintained | Buy | Buy |
| May 8, 2025 | UBS | Maintained | Neutral | Neutral |
| May 8, 2025 | Jefferies | Upgrade | Hold | Buy |
| Apr 21, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Feb 13, 2025 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 13, 2025 | UBS | Maintained | Neutral | Neutral |
| Dec 11, 2024 | Citigroup | Upgrade | Neutral | Buy |
| Dec 10, 2024 | Jefferies | Initiated | — | Hold |
| Aug 16, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Aug 1, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| May 9, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 4, 2024 | UBS | Downgrade | Neutral | Sell |
| Feb 14, 2024 | Craig-Hallum | Downgrade | Buy | Hold |
| Feb 14, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Feb 14, 2024 | Raymond James | Downgrade | Strong Buy | Outperform |
| Feb 14, 2024 | William Blair | Downgrade | Outperform | Market Perform |
| Feb 14, 2024 | JP Morgan | Downgrade | Neutral | Underweight |
| Dec 21, 2023 | RBC Capital | Maintained | Outperform | Outperform |
| Dec 11, 2023 | Citigroup | Downgrade | Buy | Neutral |
